DBH anticorps (C-Term)
Aperçu rapide pour DBH anticorps (C-Term) (ABIN361427)
Antigène
Voir toutes DBH AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- Specific for the ~75k DBH protein in Western blots.
-
Réactivité croisée
- Humain, Souris, Non-Human Primate
-
Purification
- Antigen Affinity Purified from Pooled Serum
-
Immunogène
- Synthetic peptide corresponding to amino acid residues from the C-terminal region conjugated to KLH
-
-
-
-
Indications d'application
- Recommended Dilution: WB: 1:1000 Quality Control: Western blots performed on each lot.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 100 μL in 10 mM HEPES ( pH 7.5), 150 mM NaCl, 100 μg per ml BSA and 50 % glycerol.
-
Stock
- -20 °C
-
-
- DBH (Dopamine beta-Hydroxylase (Dopamine beta-Monooxygenase) (DBH))
-
Autre désignation
- DBH
-
Sujet
- DBH catalyzes the conversion of dopamine to norepinephrine and serves as a marker of noradrenergic cells. DBH antibodies and antibodies for other markers of catecholamine biosynthesis are widely used as markers for dopaminergic and noradrenergic neurons in a variety of applications including depression, schizophrenia, Parkinson’s disease and drug abuse (Kish et al., 2001, Zhu et al., 2000, Zhu et al., 1999). The expression of DBH is also elevated during stress (Sabban and Kvetnansky, 2001). Anti-Dopamine ß-Hydroxylase Western blot of human adrenal medulla lysate showing specific immunolabeling of the ~75k DBH protein.
-
Poids moléculaire
- '75 kDa
-
ID gène
- 1621
-
UniProt
- P09172
-
Pathways
- Carbohydrate Homeostasis
Antigène
-